Management of concurrent severe COVID-19 pneumonia and antibody-mediated rejection following kidney transplantation: a case report
The timely administration of antiviral and anti-rejection therapies in the early stage of renal transplant recipient can lead to favorable outcome in case of SARS-CoV-2 infection and concurrent ABMR.
Authors
- Kailun Sun
- Hanying Li (ORCID: https://orcid.org/0000-0002-5841-6805)
- Xianpeng Zeng (ORCID: https://orcid.org/0000-0002-9664-0525)
- Qiuxiang Xia
- Heng Li (ORCID: https://orcid.org/0000-0002-3633-6679)
Institutions
- Union Hospital (HK)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-03-13
- DOI
- https://doi.org/10.3389/fmed.2025.1521785
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China